Diagnostic usefulness of tumour markers in pleural effusions Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Diagnostic utility of pleural fluid eosinophilia Source: Eur Respir J 2002; 20: Suppl. 38, 439s Year: 2002
Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Diagnostic utility of eosinophilic pleural effusion: A ten years series Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions Year: 2010
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Diagnostic utility of biochemical parameters in patients with pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
Incidence and diagnostic utility of pleural fluid eosinophilia Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases Year: 2008
Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE) Source: International Congress 2016 – Pleural diseases Year: 2016
Prognostic significance of pretreatment clinical and laboratory characteristics in patients with diffuse malignant pleural mesothelioma Source: Eur Respir J 2006; 28: Suppl. 50, 784s Year: 2006
Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Diagnostic efficacy of CA125 in the diagnosis of tuberculous pneumonitis Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020
Diagnostic assessment in tuberculous pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 413s Year: 2005
Usefulness of procalcitonin as a diagnostic marker of pleural effusion Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012
Diagnostic performance of novel and rapid tests for the diagnosis of tuberculous pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Diagnostic approach to pleural effusions Source: Annual Congress 2008 - MP7 - Diagnostic approach to pleural effusions Year: 2008
Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003
Laboratorial characteristics of pleural effusions, a new diagnostic tool for pleuropulmonary paragonimus Source: Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication Year: 2007